Discover and validate new biomarkers and biomarker signatures with our autoantibody profiling panels:
High-density profiling
Using our i-Ome® Autoantigen Panel, Sengenics can profile your samples against more than 1,600 autoimmune- and cancer-related antigens in one assay. The panel is comprised of a broad range of cellular human proteins belonging to various classes.
Profiling against cancer antigens
Using our CTA Autoantigen Panel, Sengenics can profile your samples against more than 200 clinically relevant cancer testis antigens (CTA). These tumor antigens are normally expressed in germ cells but not in adult somatic tissues. In cancers, CTA expression can be disrupted, resulting in their presence in tumors and subsequent recognition by the immune system.
Autoimmune disease autoantibody screening
Using our Pan-Autoimmune Autoantigen Panel, Sengenics can profile your samples against more than 100 clinically relevant antigens associated with a wide array of autoimmune diseases including SLE, RA, Sjögren’s and diabetes among several others.
